INTRODUCTION: There is strong evidence that pharmacist care improves @entity1 ' glycaemic control. However, the sustainability and durability of such interventions beyond the research period is not known. RxING was the first trial of pharmacist prescribing in @entity6 and it showed an improvement in glycated haemoglobin (HbA1c) of 1.8% over 6   months. OBJECTIVE: 1   objective: To evaluate glycaemic control in the RxING study @entity1 12   months after the end of the formal study follow-up. 2   objective: To assess the @entity1 ' risk of cardiovascular events in the next 10   years. METHODS: We contacted the participating pharmacists to check if the @entity1 who participated in the RxING study are still taking insulin, the dose of insulin they are taking, and their HbA1c. There were no mandated follow-up visits with the pharmacist after the study completion. RESULTS: A total of 100 @entity1 with poorly controlled type 2 @entity6 were enrolled in the original RxING study; 93 of them completed the study, while 83 participated in the 12-month follow-up. Seventy-five @entity1 were still taking insulin, with the average dose increasing from 31.1 units (SD 18.4) at study completion to 37.4 units (SD 30.8) (95% CI -13.3 to 0.88, p=0.085). HbA1c was reduced from 9.1% ( @entity15757 ) at baseline to 7.3% (SD 0.9) at study completion (95% CI 1.4 to 2, p <0.001), and increased to 8.1% ( @entity15757 .3) 12   months later (95% CI -1.1 to -0.5, p <0.001 vs study completion). CONCLUSIONS: Twelve months after completing the intervention, approximately half of the glycaemic control gains were lost. This highlights the importance of structured follow-up with the pharmacist in this @entity1 population. TRIAL REGISTRATION NUMBER: clinicaltrials.gov; Identifier: NCT01335763.

After the XXXX care trial ends, now what? A 1-year follow-up of the RxING study.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity15757 :: ('57306', 'Gene') :: ['SD 1'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes']
@entity6 :: (MESH:D003920,Disease) :: ['diabetes']
